Search Orphan Drug Designations and Approvals
-
Generic Name: | Carmustine |
---|---|
Date Designated: | 02/18/2021 |
Orphan Designation: | Treatment prior to hematopoietic stem cell transplantation in patients with relapsed or refractory non-Hodgkin lymphoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Vivus LLC 900 East Hamilton Avenue, Suite 550 Campbell, California 95008 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-